Based on the Cingulate Inc stock forecast from 1 analysts, the average analyst target price for Cingulate Inc is USD 8.00 over the next 12 months. Cingulate Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Cingulate Inc is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Cingulate Inc’s stock price was USD 4.10. Cingulate Inc’s stock price has changed by -2.61% over the past week, -8.48% over the past month and -84.11% over the last year.
No recent analyst target price found for Cingulate Inc
No recent average analyst rating found for Cingulate Inc
Company Overview Cingulate Inc
Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas. Read Less
Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in ph...Read More
Frequently Asked Questions About Cingulate Inc (CING) Stock
Based on ratings from 1 analysts Cingulate Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on CING's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for CING is USD 8.00 over the next 12 months. The maximum analyst target price is USD 8 while the minimum anlayst target price is USD 8.
Unfortunately we do not have enough data on CING's stock to indicate if its overvalued.
The last closing price of CING's stock was USD 4.10.
The most recent market capitalization for CING is USD 0.01B.
Based on targets from 1 analysts, the average taret price for CING is projected at USD 8.00 over the next 12 months.
This means that CING's stock price may go up by +95.12% over the next 12 months.
We can't find any ETFs which contains Cingulate Inc's stock.
As per our most recent records Cingulate Inc has 13 Employees.
Cingulate Inc's registered address is 1901 West 47th Place, Kansas City, KS, United States, 66205.
You can get more information about it from Cingulate Inc's website at https://www.cingulate.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Cingulate Inc (CING) Stock
Based on ratings from 1 analysts Cingulate Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on CING's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for CING is USD 8.00 over the next 12 months. The maximum analyst target price is USD 8 while the minimum anlayst target price is USD 8.
Unfortunately we do not have enough data on CING's stock to indicate if its overvalued.
The last closing price of CING's stock was USD 4.10.
The most recent market capitalization for CING is USD 0.01B.
Based on targets from 1 analysts, the average taret price for CING is projected at USD 8.00 over the next 12 months.
This means that CING's stock price may go up by +95.12% over the next 12 months.
We can't find any ETFs which contains Cingulate Inc's stock.
As per our most recent records Cingulate Inc has 13 Employees.
Cingulate Inc's registered address is 1901 West 47th Place, Kansas City, KS, United States, 66205.
You can get more information about it from Cingulate Inc's website at https://www.cingulate.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CING !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
